NCT00236834View on ClinicalTrials.gov

A Study of the Safety and Effectiveness of Levofloxacin Compared With Imipenem/Cilastatin in Patients With Pneumonia Acquired During Hospitalization

PHASE3CompletedINTERVENTIONAL

Enrollment

438

Participants

Timeline

Start Date

December 31, 1997

Study Completion Date

June 30, 2001

Conditions

Nosocomial Pneumonia

Interventions

DRUG

levofloxacin; imipenem/cilastitin

All Listed Sponsors

collaborator

PriCara, Unit of Ortho-McNeil, Inc.

INDUSTRY

lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY